K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

Zantac recall leads to federal investigation into drugmakers

On Behalf of | Sep 10, 2020 | Zantac Recall

Most people in Ohio and across the country believe that medication prescribed by their doctor or that they can buy over the counter is safe. After all, tests and approvals are needed before they can be put on the market. However, some drug manufacturers may not disclose important information about possible dangers, and as with the recent Zantac recall, investigations into those manufacturers can take place.

It was recently reported that a federal investigation is looking at Sanofi and GlaxoSmithKline, the makers of Zantac and its generic versions. Investigators are working to determine whether the drugmakers may have known about cancer-causing elements of Zantac and a generic version of the drug. The investigation is focusing on whether the companies failed to abide by the False Claims Act by not reporting that the drug contained NDMA, a suspected carcinogen.

Earlier this year, the U.S. Food and Drug Administration issued a recall of the heartburn medication due to the concerning levels of NDMA found in the product. Both manufacturers learned of the investigation and received requests for information from the U.S. Department of Justice in June. Additional information will likely be disclosed at a later time as the investigation continues.

The Zantac recall has undoubtedly left many people in Ohio and elsewhere worried about their health after using this product. If they find that they have developed cancer or other serious health conditions related to the use of this drug, they may wonder what they can do. It may be an option for some to move forward with legal action against the drug manufacturers and other liable parties in efforts to obtain compensation for the damages caused by the medication.

Archives

$120 Million Settlement

To 15,000 Asbestos Victims

$20 Million Verdict

Mesothelioma

$17 Million Verdict

Mesothelioma

$8.2 Million Verdict

Mesothelioma

White Paper Read Now2
White Paper Read Now